Opendata, web and dolomites

ReHaptix

Easy-to-use and highly accurate medical software for quantitative assessment of impairments in neurologically injured people.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ReHaptix project word cloud

Explore the words cloud of the ReHaptix project. It provides you a very rough idea of what is the project "ReHaptix" about.

market    stroke    evidences    monitor    feasibility    quantitative    neurological    limited    treating    treatment    strategy    drafted    healthcare    app    doctor    professionals    initiated    device    software    plan    lack    supply    remotely    ce    mark       mhealth    medical    clinically    perform    tablet    designed    medication    sclerosis    rehabilitation    trials    parkinson    validity    share    rehaptix    gold    adapt    autonomously    setting    ms    aged    impairments    appointment    neurologically    30m    empowers    65    grow    objectively    chain    touchscreen    validation    obtain    patients    tests    drastically    standard    worldwide    hospital    accuracy    caused    private    performing    home    validated    remote    diseases    disorders    schedule    multiple    percentage    supervised    clinical    25    solutions    people    hcps    assessments    greatest    either    population    recovery    injured    clinic    chronic    optimize    innovation    disease    progress    expensive    functional   

Project "ReHaptix" data sheet

The following table provides information about the project.

Coordinator
REHAPTIX GMBH 

Organization address
address: STAUFFACHERSTRASSE 151
city: ZURICH
postcode: 8004
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://rehaptix.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REHAPTIX GMBH CH (ZURICH) coordinator 50˙000.00

Map

 Project objective

Neurological disorders, caused by either stroke, multiple sclerosis (MS) or Parkinson’s diseases affect more than 30M people worldwide. Currently, Europe has the greatest percentage of population aged 65 or over (25%) and these numbers are expected to drastically grow (3% per year) increasing the population affected by these chronic conditions. Neurological rehabilitation is an expensive doctor-supervised program designed for treating these diseases. However, there is currently no effective assessment to objectively measure and monitor the rehabilitation progress. Current solutions for performing assessments do not provide clinical evidences of their validity, show lack of accuracy and are limited to one disease type. ReHaptix has developed a medical software, designed for remote quantitative assessment of impairments in neurologically injured people. ReHaptix has developed 9 tests so far, of which 4 have been clinically validated (the gold standard), and 5 are currently under clinical validation. Healthcare Professionals (HCPs) can use the ReHaptix tests to evaluate their patients in the hospital, rehabilitation clinic or private practice, or patients can perform the tests autonomously at home on a touchscreen tablet, which empowers them about their recovery. Furthermore, patients can remotely share their results with their HCPs, who can adapt the treatment and medication, or schedule medical appointment and home-setting assessments as required. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, ReHaptix will optimize the software increasing the number of tests and developing a functional mHealth app. Clinical trials will then be initiated to obtain the CE mark as a medical device.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REHAPTIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REHAPTIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

B2BMarketplace (2019)

The first B2B marketplace for Fast Moving Consumer Goods, connecting all brand manufacturers and retailers globally

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More  

IRMELI (2019)

AI-BASED BROKERING TECHNOLOGY PLATFORM TO FIND THE PERFECT MATCH BETWEEN THE CUSTOMER AND BANK

Read More